| Ytd | -55.06% | |
| 1y | -81.93% |
| Open | 1.15 | Prev Close | 1.20 | Low | 1.13 | High | 1.32 | Mkt Cap | 1.24M |
| Vol | 372.44K | Avg Vol | 1.39M | EPS | -3.74 | P/E | N/A | Forward P/E | -11.88 |
| Beta | 0.73 | Short Ratio | 0.09 | Inst. Own | 0.95% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 2.73 | 200-d Avg | 4.03 | 1yr Est | 256.00 |
Gainers Universe Pharmaceuticals (NASDAQ:UPC) stock moved upwards by 284.8% to $11.39 during Monday
Bluejay Diagnostics shares fall after announcing a private placement that could generate up to $23.6
$8.5 million upfront with up to approximately $15.1 million of potential additional gross proceeds u
Bluejay Diagnostics partners with Argonaut to scale U.S. manufacturing and distribution for its Symp
HPE: 30% | Hewlett Packard Enterprise shares are trading higher after the company reported better-th
Bluejay Diagnostics, Inc. ("Bluejay" or the "Company") (NASDAQ:BJDX), a medical diag